Lakshmi Amaravadi
Head, Oncology Integrated Bioanalysis Strategy, Clinical Pharmacology & Safety Sciences AstraZeneca
Seminars
Monday 3rd November 2025
Presentation Sneak Peek:
Evaluating Opportunities to Improve ADC Bioanalytical Efficiency & Understand Future Directions for ADC Immunogenicity Characterization
- Explaining challenges in ADC PK characterization across mAb, free payload, and conjugate
- Assessing bioanalytical and regulatory strategy required ADC bioanalysis in late-stage development
- Immunogenicity assessment of ADCs and what have we learned and future directions
